Entera Bio Ltd. (ENTX)
USD 2.18
(-1.36%)
USD 2.18
(-1.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 134 Thousand | 571 Thousand | 365 Thousand | 236 Thousand | 500 Thousand |
| Cost of Revenue | 56 Thousand | 101 Thousand | 373 Thousand | 209 Thousand | 210 Thousand | - |
| Gross Profit | -56 Thousand | 33 Thousand | 198 Thousand | 156 Thousand | 26 Thousand | 500 Thousand |
| Operating Expenses | 8.86 Million | 13.05 Million | 12.41 Million | 11.28 Million | 11.48 Million | 11.36 Million |
| Selling, General and Administrative Expenses | 4.43 Million | 7.25 Million | 5.69 Million | 4.89 Million | 4.28 Million | 2.84 Million |
| Research and Development Expenses | 4.51 Million | 5.84 Million | 6.77 Million | 6.39 Million | 7.19 Million | 8.51 Million |
| Other Expenses | - | -51 Thousand | -46 Thousand | 1.23 Million | 743 Thousand | 523 Thousand |
| Cost and Expenses | 8.86 Million | 13.15 Million | 12.78 Million | 11.49 Million | 11.69 Million | 11.36 Million |
| Operating Income | -8.89 Million | -13.01 Million | -12.21 Million | -11.13 Million | -11.45 Million | -10.86 Million |
| Interest Expense | - | - | 29 Thousand | 28 Thousand | 84 Thousand | - |
| Income Tax Expense | 29 Thousand | 137 Thousand | -59 Thousand | 20 Thousand | 84 Thousand | 557 Thousand |
| Earnings before Tax | -8.86 Million | -12.93 Million | -12.24 Million | -9.96 Million | -10.79 Million | -10.3 Million |
| Net Income | -8.88 Million | -13.07 Million | -12.18 Million | -9.98 Million | -10.87 Million | -10.3 Million |
| Earnings Per Share Basic | -0.31 | -0.45 | -0.47 | -0.54 | -0.90 | -1.30 |
| Earnings Per Share Diluted | -0.31 | -0.45 | -0.47 | -0.54 | -0.90 | -1.29 |
| Weighted Average Shares Outstanding | 29 Million | 28.8 Million | 26.13 Million | 18.41 Million | 12.14 Million | 7.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 29 Million | 28.8 Million | 26.13 Million | 18.41 Million | 12.14 Million | 7.98 Million |
| Gross Margin | - | 0.25 | 0.35 | 0.43 | 0.11 | 1.00 |
| EBIT Margin | - | -97.14 | -21.30 | -30.50 | -47.53 | -21.61 |
| Profit Margin | - | -97.54 | -21.34 | -27.35 | -46.10 | -20.61 |
| EBITDA | -8.8 Million | -12.87 Million | -12.16 Million | -11.1 Million | -11.34 Million | -10.8 Million |
| Earnings Before Tax Margin | - | -97.14 | -21.40 | -30.50 | -48.53 | -21.72 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 57 Thousand | - | 4.48 Million | - | - | - |
| Cost of Revenue | 48 Thousand | 13 Thousand | 13 Thousand | 56 Thousand | 14 Thousand | 15 Thousand |
| Gross Profit | 9000.00 | -13 Thousand | 4.46 Million | -56 Thousand | -14 Thousand | -15 Thousand |
| Operating Expenses | 2.17 Million | 2.04 Million | 1.96 Million | 8.88 Million | 2.38 Million | 2.33 Million |
| Selling, General and Administrative Expenses | 1.08 Million | 1.32 Million | 973 Thousand | - | 1.02 Million | 1.13 Million |
| Research and Development Expenses | 1.08 Million | 722 Thousand | 987 Thousand | - | 1.37 Million | 1.2 Million |
| Other Expenses | -1.08 Million | - | 39 Thousand | - | - | - |
| Cost and Expenses | 2.22 Million | 2.06 Million | 1.97 Million | 8.94 Million | 2.38 Million | 2.33 Million |
| Operating Income | -2.16 Million | -2.06 Million | -1.97 Million | -8.94 Million | -2.38 Million | -2.33 Million |
| Interest Expense | - | - | 32 Thousand | - | - | - |
| Income Tax Expense | -1.00 | -1.00 | 2.08 Million | 29 Thousand | 29 Thousand | 2.33 Million |
| Earnings before Tax | -2.14 Million | -2.01 Million | -1.99 Million | -8.86 Million | -2.35 Million | -2.32 Million |
| Net Income | -2.14 Million | -2.01 Million | -1.99 Million | -8.88 Million | -2.37 Million | -2.32 Million |
| Earnings Per Share Basic | -0.06 | -0.05 | -0.07 | - | -0.08 | -0.08 |
| Earnings Per Share Diluted | -0.06 | -0.05 | -0.07 | - | -0.08 | -0.08 |
| Weighted Average Shares Outstanding | 37.09 Million | 36.73 Million | 29.7 Million | 29 Million | 28.81 Million | 28.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.09 Million | 36.73 Million | 29.7 Million | 29 Million | 28.81 Million | 28.81 Million |
| Gross Margin | 0.16 | - | 1.00 | - | - | - |
| EBIT Margin | -37.79 | - | -0.44 | - | - | - |
| Profit Margin | -37.63 | - | -0.45 | - | - | - |
| EBITDA | -2.15 Million | -2.04 Million | -1.96 Million | - | -2.37 Million | -2.31 Million |
| Earnings Before Tax Margin | -37.98 | - | -0.44 | - | - | - |
TIBN
AKSHARCHEM
HINDCON
SBMFF
KRITI
300415